HAMP and cancer: Recent studies have shown that hepcidin can be also synthesized by CRC cells and functional studies have provided convincing evidence that CRC cell-derived hepcidin can target both cancer cells and tumor-infiltrating immune cells with the downstream effect of sustaining CRC cell growth and metastasis [8,9,10,11].